TP53 and cancer: These studies confirmed that the mutational signatures of carcinogens are left as ‘evidence’ in the genomes of cancer cells [10] thus spawning research which first examined the mutations across TP53 and later across multiple genes and even whole cancer genomes in order to provide a better understanding of the mutational processes involved in human carcinogenesis.